Clinical Trial: Pregabalin (Lyrica) for the Treatment of Essential Tremor

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: A Multi-site, Double-blind, Randomized, Placebo-controlled, Crossover Study of Pregabalin (Lyrica, PGB) in the Treatment of Essential Tremor

Brief Summary: This will be a multi-site, prospective, double-blind, randomized, placebo-controlled, crossover trial conducted over 6 months to assess the effectiveness and safety of PGB to treat symptoms of ET.

Detailed Summary:
Sponsor: University of South Florida

Current Primary Outcome: Fahn-Tolosa-Marin Essential Tremor Rating Scale (FTM) total score [ Time Frame: 61 days ]

Original Primary Outcome: Same as current

Current Secondary Outcome: Writing tablet recordings of tremor amplitude [ Time Frame: 61 days ]

Original Secondary Outcome: Same as current

Information By: University of South Florida

Dates:
Date Received: December 20, 2007
Date Started: December 2007
Date Completion:
Last Updated: June 15, 2012
Last Verified: June 2012